{
    "2021-08-09": [
        [
            {
                "time": "2021-08-09",
                "original_text": "晚间重要公告2021年8月9日星期一",
                "features": {
                    "keywords": [
                        "晚间",
                        "公告"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-08-09",
                "original_text": "北向资金 | 合计净流入44.66亿元，比亚迪、恒瑞医药、先导智能净买入居前",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净流入",
                        "比亚迪",
                        "恒瑞医药",
                        "先导智能"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "新能源",
                        "医药",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-09",
                "original_text": "恒瑞卡瑞利珠单抗获FDA批准在美国开展III期临床",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "卡瑞利珠单抗",
                        "FDA",
                        "III期临床"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-09",
                "original_text": "北向资金今日净买入44.66亿元，抛售隆基股份逾7亿元资产异常",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净买入",
                        "隆基股份",
                        "资产异常"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "新能源"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-08-09",
                "original_text": "A股风格分化背后：外资加仓“老白马”，两融资金涌入周期股",
                "features": {
                    "keywords": [
                        "A股",
                        "风格分化",
                        "外资",
                        "老白马",
                        "两融资金",
                        "周期股"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "消费",
                        "周期"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-09",
                "original_text": "北向资金今日净买入44.66亿元，光伏股逆势遭大幅抛售",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净买入",
                        "光伏股",
                        "抛售"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "新能源"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-08-09",
                "original_text": "恒瑞医药今日大宗交易成交4.37万股，成交价56.92元溢价0.0%",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "大宗交易",
                        "溢价"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-08-09",
                "original_text": "恒瑞医药：卡瑞利珠单抗联合苹果酸法米替尼胶囊获得美国FDA临床试验资格",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "卡瑞利珠单抗",
                        "FDA",
                        "临床试验"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-09",
                "original_text": "恒瑞医药：注射用卡瑞利珠单抗联合苹果酸法米替尼胶囊获美批准开展临床试验",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "卡瑞利珠单抗",
                        "FDA",
                        "临床试验"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-06",
                "original_text": "A股融资融券日报：两融余额增加8.43亿元（8月6日）",
                "features": {
                    "keywords": [
                        "A股",
                        "融资融券",
                        "两融余额"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}